Status:
COMPLETED
BLYS and IFN in SLE
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
Hospital for Special Surgery, New York
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
19-65 years
Brief Summary
This protocol tests whether changes in BLyS or IFN can be detected in a normal immune response to a vaccine and, if so, whether the response differs between those with lupus and healthy controls.
Eligibility Criteria
Inclusion
- ACR lupus criteria
- 18\<age\<65
Exclusion
- chronic infection or cancer
- pregnancy
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT00611611
Start Date
October 1 2007
End Date
April 1 2009
Last Update
April 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294